Oxana Beskrovnaya is CSO at Dyne Therapeutics, Inc. (DYN). They have made 1 open-market trade across 1 company since 2021, most recently 2025-03-11.
CIK 0001824542
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DYN | 195,840 | $2.8M |
Shares reported on the most recent Form 4, priced at the 2025-03-13 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DYN | SELL · 10b5-1 | 2025-03-11 | 2025-03-13 | $11.38 | $25K | -5.2% | -37.9% | +21.1% |
| DYN | SELL · 10b5-1 | 2025-03-05 | 2025-03-07 | $11.83 | $13K | +2.1% | -38.4% | +15.1% |
| DYN | SELL · 10b5-1 | 2025-02-18 | 2025-02-25 | $13.95 | $36K | -9.2% | -13.6% | -14.3% |
| DYN | SELL · 10b5-1 | 2024-12-11 | 2024-12-11 | $28.12 | $131K | -12.4% | -41.8% | -55.9% |
| DYN | SELL · 10b5-1 | 2024-11-18 | 2024-11-18 | $28.20 | $161K | +6.0% | -15.0% | -52.3% |
| DYN | SELL · 10b5-1 | 2024-09-18 | 2024-09-19 | $34.55 | $162K | -4.7% | -8.2% | -32.7% |
| DYN | SELL · 10b5-1 | 2024-09-11 | 2024-09-11 | $31.89 | $138K | +5.7% | +2.7% | -13.5% |
| DYN | SELL · 10b5-1 | 2024-08-19 | 2024-08-20 | $45.07 | $224K | -0.8% | -21.7% | -36.9% |
| DYN | SELL | 2024-06-11 | 2024-06-11 | $31.34 | $134K | +9.5% | +29.0% | -0.2% |
| DYN | SELL · 10b5-1 | 2024-05-20 | 2024-05-22 | $32.94 | $2.0M | -1.7% | +9.6% | +46.5% |
| DYN | SELL · 10b5-1 | 2024-05-16 | 2024-05-17 | $28.24 | $139K | -1.6% | +0.3% | +44.3% |
| DYN | SELL · 10b5-1 | 2024-03-11 | 2024-03-12 | $25.70 | $107K | +3.9% | +0.8% | +15.9% |
| DYN | SELL · 10b5-1 | 2024-03-07 | 2024-03-11 | $25.85 | $123K | +15.1% | +5.8% | +24.3% |
| DYN | SELL · 10b5-1 | 2024-01-03 | 2024-01-04 | $18.57 | $3.3M | -6.4% | +23.0% | +61.7% |
| DYN | SELL · 10b5-1 | 2023-12-11 | 2023-12-12 | $10.72 | $16K | +15.6% | +50.0% | +133.5% |
| DYN | SELL · 10b5-1 | 2023-09-18 | 2023-09-20 | $9.41 | $14K | -13.8% | -21.3% | +36.9% |
| DYN | SELL · 10b5-1 | 2023-09-12 | 2023-09-13 | $10.41 | $15K | -6.1% | -11.6% | +18.7% |
| DYN | SELL · 10b5-1 | 2023-06-13 | 2023-06-14 | $12.43 | $18K | -16.1% | -9.9% | -19.6% |
| DYN | SELL · 10b5-1 | 2023-03-14 | 2023-03-15 | $13.33 | $19K | -13.0% | -27.2% | +3.0% |
| DYN | SELL · 10b5-1 | 2022-12-12 | 2022-12-13 | $10.87 | $7K | -2.0% | -4.7% | +5.4% |
| DYN | SELL · 10b5-1 | 2022-03-11 | 2022-03-14 | $8.73 | $6K | +3.0% | +9.2% | -44.6% |
| DYN | SELL · 10b5-1 | 2021-09-20 | 2021-09-22 | $15.90 | $23K | -2.5% | -10.9% | -22.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.